Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Vomiting × alizapride × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 1 Neoplasms 1 Nausea 1 Breast Neoplasms 1

Interventions

Dexamethasone 49 Aprepitant 38 Palonosetron 33 Ondansetron 29 Granisetron 22 Calcium Dobesilate 14 fosaprepitant 13 Olanzapine 13 Therapeutics 8 dexamethasone acetate 7 ramosetron 6 netupitant, palosentron drug combination 6 casopitant 6 Tropisetron 6 Cyclophosphamide 6 dexamethasone 21-phosphate 5 Radiotherapy 5 Metoclopramide 5 Doxorubicin 5 netupitant 4 dolasetron 4 Acupressure 4 Vincristine 3 Tablets 3 Surveys and Questionnaires 3 Prochlorperazine 3 Lorazepam 3 Electroacupuncture 3 Dronabinol 3 Diphenhydramine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01636947 2018-09-25

KMEC

Merck Sharp & Dohme LLC

Phase 4 Completed

494 enrolled 14 charts

Nausea, Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡